SE451508B - Bestemning av substanser med tumorassocierade glykobindningar medelst lektiner som specifikt binder till terminala galaktos (beta 1 - 3 eller beta 1 - 4)-n-acetylglukosamin- eller -n-acetylgalaktosamingrupper samt cance - Google Patents

Bestemning av substanser med tumorassocierade glykobindningar medelst lektiner som specifikt binder till terminala galaktos (beta 1 - 3 eller beta 1 - 4)-n-acetylglukosamin- eller -n-acetylgalaktosamingrupper samt cance

Info

Publication number
SE451508B
SE451508B SE8000705A SE8000705A SE451508B SE 451508 B SE451508 B SE 451508B SE 8000705 A SE8000705 A SE 8000705A SE 8000705 A SE8000705 A SE 8000705A SE 451508 B SE451508 B SE 451508B
Authority
SE
Sweden
Prior art keywords
lectin
tag
labeled
cancer
body fluid
Prior art date
Application number
SE8000705A
Other languages
English (en)
Swedish (sv)
Other versions
SE8000705L (sv
Inventor
M Adachi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP943579A external-priority patent/JPS55101860A/ja
Priority claimed from JP14174179A external-priority patent/JPS5664659A/ja
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of SE8000705L publication Critical patent/SE8000705L/xx
Publication of SE451508B publication Critical patent/SE451508B/sv

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57469—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving tumor associated glycolinkage, i.e. TAG
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/827—Lectins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE8000705A 1979-01-30 1980-01-29 Bestemning av substanser med tumorassocierade glykobindningar medelst lektiner som specifikt binder till terminala galaktos (beta 1 - 3 eller beta 1 - 4)-n-acetylglukosamin- eller -n-acetylgalaktosamingrupper samt cance SE451508B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP943579A JPS55101860A (en) 1979-01-30 1979-01-30 Method of diagnosing cancer
JP14174179A JPS5664659A (en) 1979-11-01 1979-11-01 Quantitative method of glycoprotein in connection with cancer

Publications (2)

Publication Number Publication Date
SE8000705L SE8000705L (sv) 1980-07-31
SE451508B true SE451508B (sv) 1987-10-12

Family

ID=26344157

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8000705A SE451508B (sv) 1979-01-30 1980-01-29 Bestemning av substanser med tumorassocierade glykobindningar medelst lektiner som specifikt binder till terminala galaktos (beta 1 - 3 eller beta 1 - 4)-n-acetylglukosamin- eller -n-acetylgalaktosamingrupper samt cance

Country Status (10)

Country Link
US (1) US4389392A (fr)
CH (1) CH645728A5 (fr)
DE (1) DE3003301C2 (fr)
DK (1) DK36980A (fr)
ES (1) ES488747A0 (fr)
FR (1) FR2461256A1 (fr)
GB (1) GB2043890B (fr)
IT (1) IT1165552B (fr)
NL (1) NL8000536A (fr)
SE (1) SE451508B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56500521A (fr) * 1979-04-16 1981-04-23
DE3003836A1 (de) * 1980-02-02 1981-08-13 Merck Patent Gmbh, 6100 Darmstadt Verfahren und mittel zur bestimmung einer komponente aus einer gruppe bestehend aus spezifisch bindenden rezeptoren und substanzen, die von diesen rezeptoren spezifisch gebunden werden koennen
SE447028B (sv) * 1980-06-30 1986-10-20 Erik Audunn Cerven Bestemning av endstaende sackaridgrupper i glykoprotein
DE3050334C2 (de) * 1980-07-25 1986-04-17 Otsuka Pharmaceutical Co. Ltd., Tokio/Tokyo Verfahren zur Bestimmung von tumorassoziierten, glykosidische Bindungen enthaltenden Substanzen (TAGS) in einer Körperflüssigkeitsprobe und Reagenz zur Durchführung des Verfahrens
JPS5729949A (en) * 1980-07-30 1982-02-18 Nippon Koutai Kenkyusho:Kk Determination of sugar branch related to cancer and diagnostic technique of cancer
FR2520877B1 (fr) * 1982-01-29 1987-07-03 Otsuka Pharma Co Ltd Procede pour la determination des composes a liaisons gluco associes aux tumeurs
GB2114287B (en) * 1982-01-29 1985-10-30 Otsuka Pharma Co Ltd Process for determining tumor-associated glycolinkage
US4507391A (en) * 1982-04-02 1985-03-26 Sloan-Kettering Institute For Cancer Research Method for detecting the presence of GD3 ganglioside
EP0155938A1 (fr) * 1983-09-28 1985-10-02 Summa Medical Corporation Composition a base de lectine et procede de diagnostic du cancer
JPS60214737A (ja) * 1984-04-06 1985-10-28 Nippon Koutai Kenkyusho:Kk 糖鎖関連抗原の製造法
FI852545L (fi) * 1984-06-29 1985-12-30 Ortho Diagnostic Systems Inc Sandwichanalys av antikroppslektin.
JPH06105257B2 (ja) * 1984-08-07 1994-12-21 協和メデックス株式会社 癌の測定用キット
DE3432661A1 (de) * 1984-09-05 1986-03-06 Albert Prof. Dr. 6907 Nußloch Landsberger Carcinom-therapeutikum
EP0227822A1 (fr) * 1985-07-01 1987-07-08 The Trustees Of Columbia University In The City Of New York Analyse utilisant un sandwich de lectine-anticorps pour deceler la presence de glycoproteines desialylees
JPS625991A (ja) * 1985-07-03 1987-01-12 Advance Res & Dev Co Ltd コレステロ−ル乃至トリグリセリド低下活性ｒｎａ画分
ATE94395T1 (de) * 1986-05-09 1993-10-15 Pulverer Gerhard Verwendung von spezifischen monosacchariden zur herstellung eines arzneimittels zur verhinderung von metastasen maligner tumore.
US5403717A (en) * 1987-08-11 1995-04-04 Pacific Northwest Research Diagnosis of premalignant or malignant conditions of human secretory epithelia
IT1230673B (it) * 1987-09-04 1991-10-29 Sclavo Spa Metodo per la immunolocalizzazione di antigeni con l'impiego di anticorpi diretti contro epitopi di natura non glucidica
US5075218A (en) * 1987-12-29 1991-12-24 Biomira, Inc. Screening for antibodies which bind carbohydrate epitopes of tumor-associated antigens, and uses thereof
US5051354A (en) * 1988-04-15 1991-09-24 Abbott Laboratories Detection of altered IGA1 in fluid samples
TW201305B (fr) * 1991-04-03 1993-03-01 Otsuka Pharma Co Ltd
CA2055695C (fr) * 1991-04-12 2004-04-13 Thomas Hyatt Duffy Antigene immunoreactif s'apparentant au ca 195 tire du liquide amniotique humain
WO1994014071A1 (fr) * 1992-12-10 1994-06-23 Novik, Anatoly Matveevich Methode de diagnostic des tumeurs malignes chez l'etre humain
DE69422692T2 (de) * 1993-11-16 2000-07-06 Wako Pure Chemical Industries, Ltd. Verfahren zum Trennen und Messen von Glykoprotein
SE9602545L (sv) 1996-06-25 1997-12-26 Michael Mecklenburg Metod för att diskriminera komplexa biologiska prover
US20040132118A1 (en) * 2001-03-27 2004-07-08 Kiyoshi Furukawa Method of diagnosing breast cancer
US7306919B1 (en) 2001-10-31 2007-12-11 Thornthwaite Jerry T Antigen-antibody cancer recognition system
DE10249608A1 (de) * 2002-10-18 2004-05-06 Gkss-Forschungszentrum Geesthacht Gmbh Vorrichtung und Verfahren zur Strukturanalyse und Detektion von komplexen Glykostrukturen
US8632983B2 (en) 2005-04-15 2014-01-21 Van Andel Research Institute Biomarkers for pancreatic cancer and diagnostic methods
US7838634B2 (en) * 2005-04-15 2010-11-23 Van Andel Research Institute Methods for measuring glycan levels of proteins
US10753936B2 (en) 2016-07-22 2020-08-25 Van Andel Research Institute Method of detecting the level of a glycan

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4298590A (en) * 1975-02-25 1981-11-03 Samuel Bogoch Detection of malignant tumor cells
US4196186A (en) * 1975-10-09 1980-04-01 Samuel Bogoch Method for diagnosing malignant gliol brain tumors
GB1533464A (en) * 1975-02-18 1978-11-22 Bogoch S Cancer diagnostic agents
US4152410A (en) * 1975-09-03 1979-05-01 Eisai Co., Ltd. Diagnosis reagent for neoplasm and method for diagnosis of neoplasm
US4132767A (en) * 1976-04-05 1979-01-02 Eisai Co., Ltd. Preparation of α-L antibody, purification of α-L antigen and reagent for detection of α-L antibody and α-L antigen
US4174385A (en) * 1976-10-08 1979-11-13 Robert Reid Method of identification of surface proteins of cancer cells, clinical test and method of immunization
US4146603A (en) * 1977-02-18 1979-03-27 Research Corporation Tumor specific glycoproteins and method for detecting tumorigenic cancers
US4289747A (en) * 1978-12-26 1981-09-15 E-Y Laboratories, Inc. Immunological determination using lectin
US4311686A (en) * 1979-04-30 1982-01-19 The Immunology Development Corporation Methodology for the immunodiagnosis of multiple sclerosis and/or malignant diseases from blood sample analysis

Also Published As

Publication number Publication date
ES8102679A1 (es) 1981-02-16
IT1165552B (it) 1987-04-22
GB2043890A (en) 1980-10-08
FR2461256A1 (fr) 1981-01-30
ES488747A0 (es) 1981-02-16
DK36980A (da) 1980-07-31
SE8000705L (sv) 1980-07-31
FR2461256B1 (fr) 1983-11-10
US4389392A (en) 1983-06-21
GB2043890B (en) 1983-09-07
CH645728A5 (fr) 1984-10-15
IT8047743A1 (it) 1981-07-29
NL8000536A (nl) 1980-08-01
DE3003301C2 (de) 1983-12-01
IT8047743A0 (it) 1980-01-29
DE3003301A1 (de) 1980-07-31

Similar Documents

Publication Publication Date Title
SE451508B (sv) Bestemning av substanser med tumorassocierade glykobindningar medelst lektiner som specifikt binder till terminala galaktos (beta 1 - 3 eller beta 1 - 4)-n-acetylglukosamin- eller -n-acetylgalaktosamingrupper samt cance
US5122453A (en) Method for discriminating surface stained lymphocytes
EP0615129B1 (fr) Procédé pour détecter sélectivement des anticorps périnucléaires cytoplasmiques, anti-neutrophiles de colite ulcéreuse ou de cholangite primaire sclérosante
US5116724A (en) Products for separation applicable to cells in the immunopurification field
US4526871A (en) Conjugate obtained by coupling a lectin and a specific ligand, containing such a conjugate and its applications in biology
JPS6022662A (ja) 抗体、抗原または抗体：抗原複合体分析用試薬
JPS62121361A (ja) 細胞集団もしくは亜集団を定量するための方法及び標準物並びに試薬キット
JP3022930B2 (ja) 移植片受容の改良された評価
EP0165681A2 (fr) Méthode de détection de la thrombocytopénie induite par des médicaments et trousse d'immunoessai, à utiliser dans cette méthode
JPH11511851A (ja) 細胞計数イムノアッセイ
EP0746767B1 (fr) Cuvette d'analyseur, procede et trousse de diagnostic de determination des elements a analyser dans des echantillons de sang total
DK174032B1 (da) Sæt samt fremgangsmåde til immunometrisk dosering, der kan anvendes på hele celler
SE462186B (sv) Foerfarande foer bestaemning av halten tumoerassocierade glykobindningar i kroppsvaetskor
JPH0726955B2 (ja) 保存全血試料の調製方法
US4180556A (en) Pretreatment method for carcinoembryonic antigen assay
EP0057236A1 (fr) Procede de determination d'une chaine laterale de glucose associee a une tumeur, procede de diagnostic de tumeurs, et "kit" pour diagnostiquer des tumeurs
US6461825B1 (en) Immunometric assay kit and method applicable to whole cells
EP0217845B1 (fr) Procede de determination immunologique d'une substance biologique dans un echantillon
Blake et al. Genetic markers in human semen. II: Quantitation of polymorphic proteins
EP0170345B1 (fr) Cytométrie à écoulement
US6080554A (en) Methods and compositions for use in characterizing multiple sclerosis disease activity in a subject
US4582699A (en) Assay of immunoglobulin A protease and the rapid diagnosis of gonorrhea
JPH02298866A (ja) 酵素検定キット及び完全細胞に適用可能な方法
EP0166224B1 (fr) Procédé pour essayer l'anticorps du ATL-virus et réactif pour ceci
SE467987B (sv) Saett att bestaemma maengden av ett tumoerantigen-immunokomplex

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8000705-7

Effective date: 19910805

Format of ref document f/p: F